Sutherland Everett Rand bought KRYS
September 14, 2026 · Form 4 insider transaction
Sutherland Everett Rand bought 471 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
471
Price
$0.00
Total value
N/A
InsiderSutherland Everett Rand
RoleOfficer, Director
CompanyKrystal Biotech, Inc. (KRYS)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateSeptember 14, 2026
Filing dateSeptember 16, 2026
Shares owned after471
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.; The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant.